Carcinoma: all 6,719 studies
Page 6 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerRecruitingNCT06199895Phase 2
- Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06199271Phase 2
- A Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT06196775Phase 2
- A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal CancerRecruitingNCT06194734Phase 3
- Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 InhibitorRecruitingNCT06190782Phase 3
- DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCCRecruitingNCT06190665Not applicable
- A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCCRecruitingNCT06190639Phase 2
- Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)RecruitingNCT06187597Phase 2
- Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton TherapyRecruitingNCT06183268Not applicable
- A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton TherapyNot yet recruitingNCT06182865Not applicable
- CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell CarcinomaRecruitingNCT06182735Phase 1
- Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant TumorsRecruitingNCT06182644Not applicable
- Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular CarcinomaRecruitingNCT06178809
- A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT06178601Phase 2
- A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLCRecruitingNCT06177925Phase 2
- Validity of Viome's Oral/throat Cancer TestRecruitingNCT06174428
- Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCCRecruitingNCT06170710Phase 2
- Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell CarcinomaRecruitingNCT06170697Phase 2
- Study on the Quality of Life and Pathological State in Patients Who Underwent Radical CystectomyRecruitingNCT06170177
- Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated RadiotherapyRecruitingNCT06170021
- Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .Not yet recruitingNCT06168357
- Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.RecruitingNCT06167356
- Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical ResectionNot yet recruitingNCT06161909Phase 3
- A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06160557
- PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction ChemotherapyRecruitingNCT06156878Phase 2
- A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06152978Phase 2
- Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal CarcinomaRecruitingNCT06151743Phase 2
- The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell CarcinomaRecruitingNCT06150144Phase 3
- A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular CarcinomaRecruitingNCT06148155Not applicable
- Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant TherapyNot yet recruitingNCT06146777Phase 3
- A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular CarcinomaRecruitingNCT06144385Phase 1
- Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.Not yet recruitingNCT06143722Phase 2
- A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular CarcinomaNot yet recruitingNCT06143579Phase 2
- Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell CarcinomaRecruitingNCT06142318Phase 2
- A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.Not yet recruitingNCT06136988Phase 1/2
- Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of LifeNot yet recruitingNCT06136962
- Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary CancersRecruitingNCT06135896Phase 2
- A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.Not yet recruitingNCT06130007Phase 2
- Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell CarcinomaNot yet recruitingNCT06129955Phase 2
- Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue ImagingNot yet recruitingNCT06129201
- Anatomical-Clinical Base of Adenocarcinoma PancreaticRecruitingNCT06128343
- Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.RecruitingNCT06125262
- PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell CarcinomaNot yet recruitingNCT06125223
- Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular CarcinomaNot yet recruitingNCT06124001Phase 1/2
- Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell CarcinomaRecruitingNCT06122493Phase 2
- Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed IndicationsNot yet recruitingNCT06121271Phase 2
- 18F-LN1 PET/CT in Urothelial CarcinomasRecruitingNCT06120413
- QOL After SURGERY and ADJUVANT TreatmentNot yet recruitingNCT06115239
- Immunotherapy in Upper Tract Urothelial CarcinomaNot yet recruitingNCT06113367
- HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid TumorsRecruitingNCT06112704Phase 2
- BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT06111326Phase 1/2
- Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06107114Phase 2
- Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell CarcinomaRecruitingNCT06103890
- Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingNCT06102863Phase 2
- Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine CarcinomaRecruitingNCT06102746
- Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06102447Not applicable
- KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical TrialRecruitingNCT06097793Early Phase 1
- Discovering New Targets for Colorectal and Endometrial Cancer Risk ReductionRecruitingNCT06096688
- Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPCNot yet recruitingNCT06095167Phase 3
- CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal CarcinomaRecruitingNCT06095154Phase 3
- Delving Into Participation Trends in Renal Cell Carcinoma StudiesNot yet recruitingNCT06093568
- Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction ChemotherapyRecruitingNCT06092957Phase 3
- Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)RecruitingNCT06090656Phase 2
- A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical ResectionNot yet recruitingNCT06089382Phase 3
- Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular InvasionNot yet recruitingNCT06089369Phase 3
- NWRD06 DNA Plasmid for HCC After Radical ResectionRecruitingNCT06088459Phase 1
- Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC)Not yet recruitingNCT06086288Phase 2
- Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCCRecruitingNCT06081582Phase 2
- IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)Not yet recruitingNCT06078657Phase 2
- First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine CarcinomaRecruitingNCT06070740Phase 2
- bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular CarcinomaRecruitingNCT06070636Not applicable
- Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)Not yet recruitingNCT06068088
- Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell CancerNot yet recruitingNCT06067776Phase 1
- Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary CarcinomaNot yet recruitingNCT06062485Phase 2
- Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal CarcinomatosisRecruitingNCT06061874Not applicable
- bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCCRecruitingNCT06061276Not applicable
- Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell CarcinomaRecruitingNCT06056336Phase 2
- DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCCNot yet recruitingNCT06055153Phase 1/2
- A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell CarcinomaNot yet recruitingNCT06049030Phase 1
- Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06048926Not applicable
- Autologous Natural Killer Cell Therapy for Hepatocellular CarcinomaRecruitingNCT06044506Phase 1
- Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor ThrombusRecruitingNCT06040177Phase 1/2
- Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.Not yet recruitingNCT06039280Not applicable
- Exploring Merkel Cell Carcinoma Clinical Trial Engagement PatternsNot yet recruitingNCT06039033
- Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular CarcinomaRecruitingNCT06034977Phase 2
- Prospective Observational Study to Predict Severe Oral Mucositis Associated With Chemoradiotherapy in Nasopharyngeal Carcinoma Based on Deep LearningRecruitingNCT06032767
- Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint InhibitorsNot yet recruitingNCT06031480Phase 2
- GNT Induction Treatment in Locally Advanced NPCRecruitingNCT06026878Phase 3
- A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)Not yet recruitingNCT06023147Not applicable
- Nivolumab in Children and Adults With Nasopharyngeal CarcinomaRecruitingNCT06019130Phase 2
- Adelbelimab Combination Chemotherapy in Neoadjuvant Therapy for Squamous Cell Carcinoma of the Head and NeckNot yet recruitingNCT06016413Phase 2
- Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell CarcinomaRecruitingNCT06016400Phase 2/3
- Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）RecruitingNCT06011993
- Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06010212Phase 1/2
- ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid TumorsRecruitingNCT06007729Phase 2
- Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous CellRecruitingNCT06006650Phase 2
- Personalized, Adaptive Treatment for Locally Advanced Head and Neck CancerRecruitingNCT06005324Phase 1
- A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCCRecruitingNCT06003673Phase 4
- Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract CancersRecruitingNCT06001658Phase 2
- Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAICRecruitingNCT06001567Phase 2